PTS Pulse

The Move from Zionsville Road to Anson Boulevard

It is Just Moving…. It is Simple…. Right? Not So Much

As a medical device company that transacts in countries across the globe and is governed by many regulatory agencies, moving is not as simple as calling a local moving company and paying them to pack up everything and move 10 miles from our office on Zionsville Road to our headquarters in Whitestown, Indiana. Addresses are important. Registrations are important. Validation is important. Labeling is important. There is A LOT to consider, plan and coordinate, which is exactly what our teams have been doing for the last 3 years.

The move has required that any new equipment (even it is a duplicate of existing equipment) be qualified and validated.  Major existing equipment that was moved also needed to be re-qualified and/or re-validated.

From a regulatory standpoint, the move required us to re-register products in many countries. In the case of the Chinese re-registrations, we had to run three lots of product, and submit test data.  The Regulatory Affairs team has been busy (and will continue to be busy) re-registering products in over 30 countries.

And then there are documents…. Moving thousands of controlled documents that had to be signed and routed and stored in our new location has been no small feat.

But, PTS family, we are now in the home stretch, the fourth quarter, the ninth inning, the third period.  Our current plan is to be completely moved out of our Zionsville Road location by September 1st.

According to Lisa Sutton, Director of Operations, “The move started with a vision almost 3 years ago. Even though the distance was a short 10 miles, the complexity of relocating a medical device manufacturing operation can make or break a company. The move team, with the support of the Executive Team, is what made this move successful. I could not be prouder of the team, the collaboration, and the results. In August we will finally all be back together under one roof as we move the remaining operations and close the doors at Zionsville Road. The PTS story may have started there but will continue into the future in Whitestown.”

Picture of Laurie Gutzwiller

Laurie Gutzwiller

Executive Director Marketing

Separate But Together

SEPARATE BUT TOGETHER

Thank You for Your Perseverance in the Face of Uncertainty

Previous slide
Next slide

The past four months have brought unprecedented global complexities and challenges. PTS Diagnostics was not immune to the impact, as our employees — our “PTS Family”, have dealt with loss, worry, and other professional and personal challenges.

On a lighter note, those of us who were fortunate enough to work remotely during this pandemic have faced our own set of unique, and sometimes amusing challenges: dogs barking incessantly during conference calls, kids’ bike helmets falling off, a mind-numbing amount of neighborhood walks, and everyone’s favorite… e-learning! These curveballs have allowed us to have a more compassionate and sympathetic view of our co-workers now that we’ve experienced their personal challenges and have a better understanding of what a day-in-the-life can bring.

Overall, we have taken everything in stride and are poised to come out of this pandemic closer as a family than ever before with a renewed sense of purpose and passion. So on behalf of all us at PTS Diagnostics, I’d like to extend my utmost appreciation to all of our employees around the globe:

Thank you to the committed, essential employees in Operations who have been on-site every day during quarantine and have continued to work at such a high-level, in face of a global pandemic. You have maintained the high-quality for which PTS Diagnostics is known and demonstrated an unwavering commitment to your pivotal role in our success as an organization and satisfying the needs of our customers.

Thank you to our Sales teams, both domestic and international, who have transitioned their work and lifestyles from “on the road” to virtual, in order to connect with customers and maintain mindshare. You have not let the PTS Diagnostics’ voice, keeping our brand front and center as a trusted resource for so many around the globe.

Thank you to our Business Development team who continues to pursue strategic partnerships in a virtual manner in order to build out our PreVantageTM. Your creativity and perseverance is appreciated.

Thank you to our Customer Service and TSS teams, who have continued to support and troubleshoot with our customers. You have served as a valued point of contact during a time when the world was less-communicative, never letting PTS Diagnostics leave their customers without answers to their questions or solutions to their challenges.

Thank you to the Quality and Regulatory teams who have worked long hours to ensure that we remain compliant across multiple platforms and that our number one priority of FDA remediation remains on schedule. Your dedication is appreciated and the impact of your day-to-day helps keep PTS Diagnostics among the best in the industry.

Thank you to our R&D team, whose focus has remained steadfast in an ever-changing environment. You are spearheading work that can transform the world in which we live , and we recognize and appreciate that now more than ever. 

Thank you to our Finance, IT, Legal and HR teams, who have walked alongside the entire organization, through turbulence and increased uncertainty. Your presence was felt both onsite and remotely, and your leadership brought steadiness during times of not knowing what lies ahead.

Thank you to my teammates from Marketing, who have continued to find new and creative ways to reposition our brand during a time when point-of-care testing and events are largely not possible. Our strategic shift and embrace of digital platforms have allowed our brand to be viewed with expertise across many verticals. Your professionalism and teamwork have inspired me. 

Lastly, thank you to our Executive Leadership team, for your diligence in keeping up with the latest CDC and local government recommendations, so that the best decisions could be made for our health and the business and the safety of our employees. Your consistent oversight and monitoring have created an environment where PTS Diagnostics employees across the globe know that we are on the continued path toward success.

We will come out of this stronger together and continue to provide superior quality, point-of-care solutions, while closing gaps in care for patients with chronic disease; including diabetes, cardiovascular disease and other related comorbidities

Are we missing any person or group that deserves recognition? Email genericmarketing@ptsdiagnostics.com and we’ll include a shout-out in the next quarterly newsletter. 

Until then, feel free to swing by my office (the one decorated like a summer camp) and say hello – it is great to be back under our roof in Whitestown!

Ryan Simpson

Marketing Communications

PTS Diagnostics and MedPro Healthcare Sales Solutions Enter Into Partnership

PTS Diagnostics and MedPro Healthcare Sales Solutions Enter Into Partnership

Effective immediately, augments existing accomplished sales force

WHITESTOWN, Ind. (April 1, 2020) – PTS Diagnostics, a U.S.-based manufacturer of point-of- care medical testing devices announced today that they are partnering with MedPro Healthcare Sales Solutions, a leading healthcare contract sales organization.

The partnership adds positions to the existing PTS Diagnostics sales force. These new representatives will be strategically staggered throughout the country and managed by PTS Diagnostics directors and senior sales managers. Together they’ll be responsible for expanding the footprint of the CardioChek® and A1CNow® product lines.

“MedPro’s support is crucial to achieving our core mission of closing gaps in care and potentially improving the outcomes of individuals with chronic conditions such as diabetes and cardiovascular disease,” said Cliffe Allen, VP of U.S. Sales of PTS Diagnostics. “Their knowledge regarding point-of-care testing combined with exceptional distribution relationships positions us for ongoing success in numerous vertical markets.”

MedPro was founded in 2006 and has grown into a leading sales force that’s trusted by manufacturers and distributors of all sizes. Their team’s connections span across a wide spectrum of healthcare delivery models, allowing for a streamlined sales cycle.

PTS Diagnostics’ solutions represent the first and only point-of-care lipid, glucose, and HbA1c tests sold by MedPro representatives.

“We’re thrilled to partner with PTS Diagnostics and believe that the certified accuracy, precision, and speed of their solutions will be a value add for physician offices, pharmacies, walk-in clinics, and more,” said Manny Losada, President of MedPro Healthcare Sales Solutions. Together we hope to positively impact at-risk populations at the point of care.

This announcement comes on the heels of PTS Diagnostics’ recent A1CNow+ Controls™ product launch and it precedes future 2020 product announcements.

To learn more about PTS Diagnostics or to connect with a sales representative, email: customerservice@ptsdiagnostics.com, or call 877-870-5610.

About PTS Diagnostics

Through its People, Technology and Service, PTS Diagnostics creates health innovation that drives action and results. Since 1992, we have helped medical professionals and patients achieve better health outcomes through our accurate, precise, fast, affordable, and certified point-of-care medical devices. Healthcare professionals have used our CardioChek products to assess cardiovascular disease risks for millions of patients worldwide through lipid panel screening. And, our A1CNow® systems, which provide fast and reliable HbA1c testing, have helped physicians deliver more effective treatments to patients with diabetes. For more information, visit ptsdiagnostics.com.

About MedPro Healthcare Sales Solutions

Med-Pro Associates is a nationwide independent rep group specializing in representing leading manufacturers across the country who sell their products both through distribution and direct to the hospital, long term care, physician, dental and veterinary markets.

Press Contact

Ryan Simpson, Marketing Communications
317-870-5610 –  rsimpson@ptsdiagnostics.com

PTS Diagnostics Response to COVID-19

Dear Valued Customers,

The spread of COVID-19 has brought significant challenges to our global community, including unprecedented pressure on healthcare providers and manufacturers.

At PTS Diagnostics we recognize the incredible contribution of all healthcare professionals. We thank you for your dedication, compassion and courage during this difficult time. We are proud to count you as our customers, and to be part of the broader healthcare community engaged in helping to manage this crisis.

We would like to provide you an update on our product availability.  To date we have continued to work at full capacity with no significant disruptions to product availability. We will continue to monitor our inventory levels and supply chain elements closely as this a very fluid situation given the global nature of this issue.  Some of our suppliers have certainly been impacted and others will be if they have not as of yet. We will keep you posted if we believe there will be disruption to product availability.

It is very important that we have visibility to upcoming demand. We also encourage you to place orders in a timely fashion so that we can ensure you have no interruption in your business and to guard against a potential future supply disruption.

On behalf of PTS, we thank you for your business and wish you, your employees and your families the best and hope that you remain safe and in good health.

 

Jonathan Chapman, President and CEO